The largest database of trusted experimental protocols

Sanger method

Manufactured by Genewiz
Sourced in United States

The Sanger method is a DNA sequencing technique used to determine the nucleotide sequence of a DNA molecule. It is based on the enzymatic chain-termination method developed by Frederick Sanger and his colleagues in the 1970s. The Sanger method involves the use of modified nucleotides that terminate DNA synthesis, allowing for the generation of DNA fragments of varying lengths, which can then be separated and analyzed to determine the sequence of the original DNA molecule.

Automatically generated - may contain errors

12 protocols using sanger method

1

Comprehensive Antibiotic Resistance Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using PCR and sequencing, we tested the main mechanisms of resistance to ciprofloxacin (mutations in the QRDR), amikacin and tobramycin (the presence of AMEs), aztreonam, meropenem, imipenem, piperacillin/tazobactam, ceftazidime, ceftazidime/avibactam, ceftolozane/tazobactam and cefepime (production of β-lactamases) and colistin (mcr genes). Mutations in oprD and post-transcriptional regulator genes (nalC, nalD, mexR, nfxB, mexT, mexS and mexZ) were also determined by PCR and sequencing. Gene expression analysis was conducted by quantitative RT–PCR (RT–qPCR). The primers and conditions are shown in Table 1. The PCR products were sequenced by Sanger methods (GENEWIZ, Germany), and were analysed by alignment with the template sequence in GenBank.
+ Open protocol
+ Expand
2

Retromer Electrostatic Mutant Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retromer constructs were generated in the labs of David Owen and Brett Collins and have been published previously (Collins et al., 2005 (link), 2008 (link)). We used a two-stage quick-change mutagenesis protocol adapted from Wang and Malcolm (Biotechniques 1999) to introduce point mutations into retromer plasmids to generate retromer electrostatic mutants. Briefly, mutagenic primers (Sigma) were created for the desired mutations. In the first step, two polymerase chain reactions (PCRs), with either the mutagenic 5’ or 3’ primer, were amplified around the plasmid. The two reactions were then combined in an additional PCR step, and the product was digested using Dpn I. Digested product was used to transform XL1 Blue (Agilent) competent cells, and colonies were sequenced using Sanger methods (Genewiz).
+ Open protocol
+ Expand
3

Sanger Sequencing for CRISPR Gene Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNAs from LE exposed to the RNPs were isolated as described [1 (link)]. The target omega-1 locus in the replicates of gDNAs was amplified using a control primer pair (Figure 2a). The amplicon of 790 bp in size from control and experimental groups, both KO and KI focused manipulations, was purified by NucleoSpin® Gel and PCR clean-up (Macherey-Nagel, Bethlehem, PA, USA) after which the nucleotide sequence was determined by the Sanger method (Genewiz, South Plainland, NJ, USA). Sanger sequence traces from the twelve independent replicates of the experimental groups for both SpCas9- or AsCas12a- [27 (link)]-catalyzed gene editing manipulations were analyzed and compared with reads from the control (mock) group using the tracking of indels by decomposition (TIDE) algorithm [71 (link),72 (link),73 (link)]. TIDE provides a rapid and informative assay and also informs decisions on whether proceed to more detailed high-throughput, next-generation sequencing (NGS) of targeting amplicons [74 (link)].
+ Open protocol
+ Expand
4

Biotinylation of protein kinases

Check if the same lab product or an alternative is used in the 5 most similar protocols
pDEST-pcDNA5-BirA∗-FLAG N-term and pDEST-pcDNA5-BirA-FLAG-GFP were a gift from Dr Anne-Claude Gingras (Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital). The entry clones pENTR221 CK2A1 and pENTR221 PRKACA were purchased from DNAFORM and RIKEN BRC through the National BioResource Project of the MEXT/AMED, Japan, respectively. CK2A1 or PRKACA coding sequences were cloned into the destination vector pDEST-pcDNA5-BirA∗-FLAG N-term with LR clonase 2 (Thermo Fisher Scientific) using the Gateway system. Sequences of all constructs were confirmed by the Sanger method (Genewiz).
+ Open protocol
+ Expand
5

Purification, Sequencing, and Alignment of PCR Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PCR products were purified using the Qiagen PCR purification kit as per the manufacturer’s instructions (QIAGEN, CA, USA). The purified products of all the four genes were sequenced bidirectionally using Sanger method (Genewiz INC, NJ, USA). Sequences were manually cured and Expasy translate software was used for translation of the sequences. Clustal X 2.1 was used for performing multiple sequence alignment (MSA) to see intraspecific variation (SNPs) if any, among the sequences on comparison with Sal-I reference sequence.
+ Open protocol
+ Expand
6

Genotyping Malaria Drug Resistance Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmodium falciparum samples were genotyped using PCR or nested PCR followed by Sanger sequencing to evaluate mutations at pfcrt gene (codons 72–76), pfdhfr gene (codons 51, 59, 108, and 164), and pfdhps gene (codons 436, 437, 540, and 581). Primer sequences and PCR cycling conditions for each gene are reported elsewhere [12 (link)–14 (link)]. Briefly, primary PCR was performed with 1 μL genomic DNA, 7.5 μL of 2X master mix (Promega, Madison, WI, USA), and 0.27 μM each primer in 15 μL final volume for pfdhfr and dhps genes. Conditions for pfcrt gene were the same, except 1.2 μL of DNA and a final concentration of 0.33 μM each primer. Nested PCR was done for pfdhps and pfcrt genes. PCR products were purified with ExoSAP-it reagent (New England Biolabs, Ipswich, MA, USA) and sequenced using the Sanger method (Genewiz INC, NJ, USA). Laboratory P. falciparum strains, 3D7 and 7G8, were used as wild-type and mutant-type controls, respectively. Sequence analysis was performed using Geneious® 7.1.7 software (Biomatters, Auckland, New Zealand) using the P. falciparum 3D7 reference strain for pfcrt (PF3D7_0709000), pfdhfr (PF3D7_0417200), and pfdhps (PF3D7_0810800) genes. Mutant alleles were identified, and the frequency of each allele was determined.
+ Open protocol
+ Expand
7

Reverse Transcription and Cloning of Influenza A Virus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted by using the RNeasy kit (Qiagen, Inc., Gaithersburg, MD, United States) following the manufacturer’s instructions. Reverse transcription was carried out using the Uni12 primer (5′-AGCAAAAGCAAGG-3′) and avian myeloblastosis virus (AMV) reverse transcriptase (Takara) following the manufacturer’s instructions and the cDNA products were stored at −80°C until use. The eight segments of influenza A virus were amplified by PCR using universal primers (Wang et al., 2017 (link)) and Phusion high-fidelity DNA polymerase (Vazyme, Inc., Nanjing, China). The PCR products were cloned into the pHW2000 vector using an in vitro recombination approach (Wang et al., 2017 (link)). The cloned plasmids were confirmed by sequencing with the Sanger method (Genewiz, Inc., Suzhou, China) with primers: 5′-CGCAAATGGGCGGTAGGCGTG-3′ (CMV-Forward) and 5′-TAGAAGGCACAGTCGAGG-3′ (BGH-Reverse). The eight segments of H9N2 virus were analyzed and aligned by using MEGA6 software (Tamura et al., 2013 (link)).
+ Open protocol
+ Expand
8

Single-Cell Genotypic Analysis of CRISPR Edits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Our initial genotypic analysis of the single-cell clones isolated from the SfMgat1t4 transformed polyclonal cell population involved PCR amplifying and sequencing the targeted region of the Sfmgat1 gene (Fig. S1) in the parental Sf-RVN or SfMgat1t4 cell clones, and then using the TIDE program to deconvolute the results. Briefly, genomic DNA preparations were isolated from the parental cell line and samples from the first passage of all 11 SfMgat1t4 cell clones using the DirectPCR lysis reagent (Viagen Biotech). The approximate locations of the primers used for PCR and the size of the amplification product are shown in Fig. S1. The PCRs were performed using 2 μl of genomic DNA lysate as the template, Q5 DNA polymerase (New England Biolabs), and 0.2 mM dNTPs. The PCRs included 30 cycles of denaturation at 98 °C for 10 s, annealing at 60 °C for 10 s, and extension of 72 °C for 30 s. The amplification products were purified on Omega Bio-Tek minispin columns, sequenced using the Sanger method (24 (link)) (GENEWIZ, Inc), and the results were analyzed using the TIDE algorithm (http://shinyapps.datacurators.nl/tide/) to predict the genome-edited ratios obtained in each SfMgat1t4 cell clone, as described previously (16 (link), 25 ).
+ Open protocol
+ Expand
9

Sequencing of Novel Umbravirus from Sugarcane

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-PCR reactions were carried out to extend the genomic sequence of a novel umbravirus isolated from sugarcane variety BJ790038, for which four short contigs (131–325 nt) were recovered using the VANA-based metagenomics approach. PCR reactions were performed using the Qiagen OneStep RT-PCR Kit. Ten primers were designed (Table S1) based on the four contig sequences. The 25 μL RT-PCR reaction mix consisted of 1 μL of eluted RNA, 14.5 μL of RNase-free water, 1µl of RNase inhibitor (RNase-Out, Invitrogen), 5 μL of RT-PCR buffer (5X), 0.5 μL of dNTPmix (10 mM), 1 μL of each primer (10 μM), and 1 μL of the RT-PCR enzyme mix. The RT-PCR program was as follows with the extension time (Ext) for each primer pair listed in Table S1: 50 °C for 30 min, 95 °C for 15 min, 35 cycles at 94 °C for 1 min, annealing temperature 55 °C for 1 min, and 72 °C for Ext with a final 72 °C extension for 10 min. PCR products were analyzed by electrophoresis using a 1.2% agarose gel in TAE buffer stained with ethidium bromide and visualized under UV light. Amplification products were sequenced using the Sanger method (Genewiz, Leipzig, Germany).
+ Open protocol
+ Expand
10

TRPC3 Exon 9 Amplification in DMD Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR amplification of the coding region around the exon 9 of the TRPC3 cDNA was performed on total cDNA from EDL of WT and DMDmdx rats. PCR was performed using LA Taq polymerase (Takara, Kusatsu, Japan) and the primers published by Kim and collaborators [36 (link)]: Forward: CAGTGATGTAGAGTGGAAGTTTGC, Reverse: CTCCCTCATTCACACCTCAGC. The amplification products were loaded on a 2% agarose gel. The amplification of the full-size cDNA of TRPC3 was performed using the following primers: Forward: ACGCAGTACGGCAACATCC, and Reverse: CATTCACACCTCAGCGCACT. The amplification products were then sequenced with Sanger method (Genewiz, South Plainfield, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!